Literature DB >> 25234797

Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography.

Nilgun Ustun1, Mustafa Kurt, Alper Bugra Nacar, Hacer Paksoy Karateke, Hayal Guler, Ayse Dicle Turhanoglu.   

Abstract

The aim of this study was to evaluate left ventricular systolic and diastolic function using speckle tracking echocardiography (STE) in order to detect subclinical left ventricular dysfunction in patients with ankylosing spondylitis (AS). Twenty-six AS patients (age 43.7 ± 11.8 years, disease duration 11.83 ± 10.98 years) and 26 healthy controls, matched for age, sex, body mass index, and smoking, were enrolled in this cross-sectional study. All patients underwent two-dimensional, Doppler, tissue Doppler, and speckle tracking echocardiography. The mitral early/late diastolic inflow velocity ratio (1.0 ± 0.4 vs. 1.5 ± 0.5; p < 0.001) and the mitral E-wave velocity (8.1 ± 2 vs. 11.1 ± 3; p < 0.001) were lower in the AS patients than in the controls. The ejection fraction did not differ between the patients and controls (64 ± 4.2 vs. 64.8 ± 2.3; p = 0.402). All segments showed a significant decrease in left ventricular diastolic and systolic strain values in the patients with AS when compared with the healthy controls (p < 0.001). Despite no clinical evidence of cardiovascular disease, patients with AS may have impaired left ventricular systolic function as assessed by STE.

Entities:  

Mesh:

Year:  2014        PMID: 25234797     DOI: 10.1007/s00296-014-3130-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Ankylosing spondylitis--cardiac manifestations.

Authors:  D Lautermann; J Braun
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

2.  Feasibility and accuracy of different techniques of two-dimensional speckle based strain and validation with harmonic phase magnetic resonance imaging.

Authors:  Manish Bansal; Goo-Yeong Cho; Jonathan Chan; Rodel Leano; Brian A Haluska; Thomas H Marwick
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

3.  Echocardiography in serial evaluation of left ventricular systolic and diastolic function: importance of image acquisition, quantitation, and physiologic variability in clinical and investigational applications.

Authors:  H F Kuecherer; L L Kee; G Modin; M D Cheitlin; N B Schiller
Journal:  J Am Soc Echocardiogr       Date:  1991 May-Jun       Impact factor: 5.251

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

6.  Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?

Authors:  Florian Brunner; Andres Kunz; Ulrich Weber; Rudolf Kissling
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

7.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Authors:  K A Krown; M T Page; C Nguyen; D Zechner; V Gutierrez; K L Comstock; C C Glembotski; P J Quintana; R A Sabbadini
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

8.  Impaired left ventricular apical rotation is associated with disease activity of psoriatic arthritis.

Authors:  Qing Shang; Lai-Shan Tam; John E Sanderson; Alex Pui-Wai Lee; Edmund Kwok-Ming Li; Cheuk-Man Yu
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study.

Authors:  D A Brewerton; D G Gibson; D H Goddard; T J Jones; R B Moore; C T Pease; P A Revell; L M Shapiro; K V Swettenham
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

View more
  5 in total

Review 1.  Echocardiography in the Assessment of Patients with Rheumatologic Diseases.

Authors:  Maha A Al-Mohaissen; Kwan-Leung Chan
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

2.  Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis.

Authors:  Sadık Volkan Emren; Onay Gerçik; Emre Özdemir; Dilek Solmaz; Nihan Eren; Ersin Çağrı Şimşek; Mehmet Tokaç; Zeynep Emren; Gökhan Kabadayı; Servet Akar
Journal:  Eur J Rheumatol       Date:  2019-11-25

3.  Assessment of left atrial function using speckle tracking echocardiography in ankylosing spondylitis: a case-control study.

Authors:  Murathan Kucuk; Necmettin Korucuk; Veysel Tosun; Mediha Cavusoglu; İbrahim Basarici
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-16       Impact factor: 2.357

4.  Echocardiographic and Electrocardiographic Findings in Patients with Ankylosing Spondylitis without Cardiovascular Risk Factors.

Authors:  Simin Almasi; Behzad Farahani; Niloufar Samiei; Yousef Rezaei; Habib Mahmoodi; Mostafa Qorbani
Journal:  J Tehran Heart Cent       Date:  2020-04

5.  Evaluation of Right Ventricular Function by Speckle-Tracking Echocardiography in Patients with Ankylosing Spondylitis: A Case-Control Study.

Authors:  Mustafa Zungur; Ilker Gul; Senol Kobak
Journal:  Acta Cardiol Sin       Date:  2018-03       Impact factor: 2.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.